Avanos Medical appoints Indrani Franchini to Board of Directors, effective July 1, 2024

AVANOS MEDICAL, INC.

Appointment fills a vacancy; Franchini will serve on Audit and Compliance Committees.
Compensation includes $70,000 annual cash retainer, $12,500 Audit, $7,500 Compliance, and $190,000 RSU grant.
Board now comprises 6 directors (5 independent) with 3 women, 2 ethnically diverse.
Franchini previously EVP/CLO at Alnylam, EVP/CCO at Alexion, and roles at Hess and Pfizer.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Indrani Franchini

Director

AVNS · AVANOS MEDICAL, INC.

Effective: 2024-07-01
Filed: July 1, 2024, 7:59 PM ET

On June 28, 2024, the Board of Directors (the “Board”) of Avanos Medical, Inc. (the “Company”) appointed Indrani Franchini to the Board, effective July 1, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Indrani Franchini was appointed as Director at AVANOS MEDICAL, INC..

Action: appointed
Role: Director

Exact text from the filing

On June 28, 2024, the Board of Directors (the “Board”) of Avanos Medical, Inc. (the “Company”) appointed Indrani Franchini to the Board, effective July 1, 2024.

View on SEC.gov

AVANOS MEDICAL, INC. filing history →

Source: SEC EDGAR

accession 0001606498-24-000069

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.